GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation

GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation

Glucagon-like peptide 1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) are two class B1 G protein-coupled receptor…

What is GLP-1, the weight-loss medicine that is transforming consumption?

The rise of GLP-1 drugs for weight loss represents a remarkable shift in the way people pursue their health and wellness goals. It also appears to have begun reshaping consumer habits. On the eve of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group released the findings of its latest proprietary study focused on GLP-1— a class of medicines that has gained tremendous attention in recent years for its effectiveness…

Rising awareness of GLP-1/GIP weight loss drugs reported in women

A UK survey reveals growing recognition and interest in obesity medications such as semaglutide and tirzepatide, with women showing significantly higher awareness and understanding.